Developments at Cymaris Labs Columbus Nanoworks

September 2019 – NCI Phase I SBIR Contract Award
Columbus Nanoworks awarded Phase I contract from the NIH National Cancer Institute (NCI) to develop the use of fluorescent nanodiamonds for cancer immunotherapy applications.  This award is part of the NCI Moonshot Initiative.

June 1, 2019 – NIGMS Phase I SBIR Grant Completed
Columbus Nanoworks successfully completes NIGMS Phase I grant.

May 1, 2018 – NIGMS Phase I SBIR Grant Award
Columbus Nanoworks awarded Phase I contract from the NIH National Institute of General Medical Sciences (NIGMS) to develop an enzymatic method for attachment of proteins to fluorescent nanodiamond surfaces.

April 30, 2018 – NHLBI Phase II SBIRContract Completed
Columbus Nanoworks successfully completes NHLBI Phase II contract.

July 31, 2015 – NHLBI Phase II SBIR Contract Award
Columbus Nanoworks awarded Phase I contract from the NIH National Heart, Lung, Blood Institute (NHLBI) to continue development of fluorescent nanodiamonds for in vitro and in vivo biological imaging.

August 2014 – NHLBI Phase I SBIR Contract Completed
Columbus Nanoworks successfully completes NHLBI Phase I contract.

September 2013 – NHLBI Phase I SBIR Contract Award
Columbus Nanoworks awarded Phase I contract from the NIH National Heart, Lung, Blood Institute (NHLBI) to develop fluorescent nanodiamonds for in vitro and in vivo biological imaging.